In one of the focus groups, there was no disagreement when one participant asked, [d]oes it feel almost inevitable that those drugs are going to become part of our formulary? Our insurance provider, Cigna told us that within the next 9 to 12 months, theres really not going to be a choice, that all insurance companies are probably going to be covering GLP-1s for weight loss. Occupational health manager, large manufacturer The use of GLP-1 drugs for weight loss is still new for many employers, and many are not sure how or whether they can manage the benefit
Kuswanto W, Baker MC
For the top two quintiles, we reduce the cost (if insurance fails, they pay cash) For the bottom 3 quintiles, we unlock access (if insurance fails, paying cash is extremely challenging and often unmanageable) The net effect of the status quo is: Top 2 quintiles, regardless of coverage, will get access Bottom 3 quintiles, need insurance coverage to get access Impact of the Body Program on access One of the challenges in increasing access is that the top two quintiles are the ones that most likely have access to the best doctors offices in the world who are going to be best at handling the significant support required for coverage (i.e., hand-to-hand combat with insurance companies)
In addition, the expression of envelope proteins L/M/SHBs in the cells was increased and HBsAg in the culture supernatant was also increased by 4-10 fold
.webp)
